Zobrazeno 1 - 10
of 21
pro vyhledávání: '"G A, Curt"'
Autor:
G. A. Curt
Publikováno v:
The Oncologist. 5:9-12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7738759f14b886169dfce5f47e9400cb
https://doi.org/10.1634/theoncologist.5-2004-9
https://doi.org/10.1634/theoncologist.5-2004-9
Autor:
G A, Curt
Publikováno v:
Recenti progressi in medicina. 92(6)
As oncologists have become more effective in alleviating pain, nausea and depression, fatigue has emerged as the most important symptom suffered by cancer patients. Indeed, the current literature suggests that fatigue is currently the most important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef0c14ea1c44a2796123002ed9ec2804
https://pubmed.ncbi.nlm.nih.gov/11433722
https://pubmed.ncbi.nlm.nih.gov/11433722
Autor:
N J, Vogelzang, W, Breitbart, D, Cella, G A, Curt, J E, Groopman, S J, Horning, L M, Itri, D H, Johnson, S L, Scherr, R K, Portenoy
Publikováno v:
Seminars in hematology. 34(3 Suppl 2)
Although fatigue is the most common symptom reported by cancer patients and has serious adverse effects on quality of life, it remains poorly understood. A survey was designed to characterize the epidemiology of cancer-related fatigue from the perspe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::045c8a6cd1985d90cd705da2c5caebf7
https://pubmed.ncbi.nlm.nih.gov/9253778
https://pubmed.ncbi.nlm.nih.gov/9253778
Autor:
P. D. Porter, G. A. Curt, B. J. Miller, J. A. Hautala, James H. Doroshow, D. Shoemaker, Sheila A. Prindiville
Publikováno v:
Journal of Clinical Oncology. 29:e16600-e16600
e16600 Background: Negotiation of clinical trial agreements (CTAs) between industry and academic medical centers is one of the barriers to timely initiation of cancer clinical trials. It is perceiv...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::139731ec27d7976fdd5f5fe70b77d43e
https://doi.org/10.1200/jco.2011.29.15_suppl.e16600
https://doi.org/10.1200/jco.2011.29.15_suppl.e16600
Publikováno v:
JAMA: The Journal of the American Medical Association. 255:505-507
Immunoaugmentative therapy is an unproved cancer treatment that until recently was offered to patients by zoologist Lawrence Burton, PhD, at a facility in Freeport, Bahamas. The therapy consists of serum measurements of certain "immune deficiencies"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8efd021ca360d6711ca6dad5b6567915
https://doi.org/10.1001/jama.255.4.505
https://doi.org/10.1001/jama.255.4.505
Publikováno v:
British Journal of Cancer
Two cell lines, one sensitive and one resistant to the cytotoxic effects of cytosine arabinoside (AraC) were studied in vitro as a drug-resistance model. The sensitivity of these cell lines, to the effects of free and liposomally trapped AraC and Ara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e91e8113276d724b052d65da7abb443
https://pubmed.ncbi.nlm.nih.gov/7073946
https://pubmed.ncbi.nlm.nih.gov/7073946
Publikováno v:
Cancer treatment reports. 69(6)
A competitive protein-binding assay has been developed for trimetrexate (TMTX) based on the tight binding of this drug to human dihydrofolate reductase (tetrahydrofolate dehydrogenase). In this assay, TMTX competes with 3H-methotrexate for binding to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1dabfe0dc1231cb94363224c7f2349d2
https://pubmed.ncbi.nlm.nih.gov/3160459
https://pubmed.ncbi.nlm.nih.gov/3160459
Autor:
G A, Curt
Publikováno v:
The New England journal of medicine. 311(13)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2179ce2f6dd8024ccc2f6c56e133a880
https://pubmed.ncbi.nlm.nih.gov/6472390
https://pubmed.ncbi.nlm.nih.gov/6472390
Publikováno v:
Cancer treatment reports. 67(10)
Data are presented from two cell culture systems which support the notion that a multi-drug-resistant phenotype occurs in human tumor cell populations. Human small cell lung cancer cell lines derived from patients in relapse following intensive combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19aa3cf1320eae0d23bd0e284b714337
https://pubmed.ncbi.nlm.nih.gov/6313186
https://pubmed.ncbi.nlm.nih.gov/6313186
Autor:
G A, Curt, J A, Kelley, R L, Fine, P N, Huguenin, J S, Roth, G, Batist, J, Jenkins, J M, Collins
Publikováno v:
Cancer research. 45(7)
5,6-Dihydro-5-azacytidine (DHAC; NSC 264880) is an analogue of 5-azacytidine that does not possess the hydrolytically unstable 5,6-imino bond of the parent compound. Thus, unlike 5-azacytidine, DHAC is stable in aqueous solution and may be administer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b7debfd24691b2b4f2916f972cad614
https://pubmed.ncbi.nlm.nih.gov/2408749
https://pubmed.ncbi.nlm.nih.gov/2408749